U S Physical Therapy Inc /NV
USPH· Services· Fiscal year ends in December
Christopher J. Reading is the CEO of U S Physical Therapy Inc /NV and was paid $4.5M in FY2025 (Dec), up 23%.
Executives5
See all- 1Christopher J. ReadingChief Executive OfficerFY2025
- 2Eric J. WilliamsPresident, Chief Operating Officer - EastFY2025
- 3Graham D. ReeveChief Operating Officer - WestFY2025
- 4Carey P. HendricksonChief Financial OfficerFY2025
- 5Richard S. BinsteinExecutive Vice President, General Counsel and SecretaryFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allU S Physical Therapy Inc /NV paid its 5 named executives $13.0M in total in FY2025 (Dec). CEO Christopher J. Reading was paid $4.5M of that.
| Name | |||
|---|---|---|---|
| Christopher J. ReadingChief Executive Officer | |||
| Eric J. WilliamsPresident, Chief Operating Officer - East | |||
| Graham D. ReeveChief Operating Officer - West | |||
| Carey P. HendricksonChief Financial Officer | |||
| Richard S. BinsteinExecutive Vice President, General Counsel and Secretary |
of each named executive, from the Summary Compensation Table of each proxy.
Peers10
See allThe FY2025 (Dec) proxy of U S Physical Therapy Inc /NV names 10 peer companies for pay. Among U S Physical Therapy Inc /NV and these peers, CEO pay was 5th highest of 7 and total shareholder return was 5th highest of 7.
5th highest of 7in U S Physical Therapy Inc /NV and its pay peers, FY2025 (Dec) by CEO pay:
5th highest of 7in U S Physical Therapy Inc /NV and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 16, 2026 | FY2025 |
| Annual report | 10-K | Feb 27, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 11, 2025 | FY2024 |
| Annual report | 10-K | Mar 3, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 15, 2024 | FY2023 |
| Annual report | 10-K | Feb 29, 2024 | FY2023 |